FDA approves Protalix's (PLX) Gaucher Disease drug Elelyso
The FDA approved Protalix's (NYSE: PLX) Gaucher Disease drug Elelyso
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer (PFE) Terminates Repligen (RGEN) License Agreement for Treatment of Spinal Muscular Atrophy
- OPKO Health (OPK) Submits Factor VIIa Phase 2a IND to U.S. FDA
- Vericel (VCEL) Completes Enrollment in Phase 2b Study of Ixmyelocel-T
Create E-mail Alert Related CategoriesFDA, Hot FDA News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!